Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$137.72 USD

137.72
562,365

+1.77 (1.30%)

Updated Jul 16, 2024 04:00 PM ET

After-Market: $137.80 +0.08 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Founded in 1994 and headquartered in Denver, CO, DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.

Top Ranked Momentum Stocks to Buy for November 22nd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 22nd

Nalak Das headshot

Shrug Off Market Gyrations With These Top 5 Value Picks

A strong rally is unlikely for as long as this trade conflict continues. However, the downside potential will be limited owing to U.S. economic strength.

Why DaVita HealthCare (DVA) Might be Well Poised for a Surge

DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

Are Investors Undervaluing DaVita HealthCare (DVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Nitish Marwah headshot

New Strong Buy Stocks for November 12th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.

DaVita (DVA) Earnings and Revenues Beat Estimates in Q3

DaVita (DVA) raises guidance for 2019 following impressive Q3 results.

DaVita HealthCare (DVA) Surpasses Q3 Earnings and Revenue Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 24.39% and 1.81%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for DaVita (DVA) This Earnings Season?

DaVita (DVA) expects to have gained from calcimimetics in the third quarter.

DaVita HealthCare (DVA) Earnings Expected to Grow: Should You Buy?

DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain DaVita (DVA) Stock for Now

DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, integration risks remain a concern.

Kinjel Shah headshot

5 Low Price-to-Book Stocks to Increase Your Portfolio's Value

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

DVA vs. AMED: Which Stock Should Value Investors Buy Now?

DVA vs. AMED: Which Stock Is the Better Value Option?

Urmimala Biswas headshot

5 Buffett-Style Value Picks Boasting Impressive PEG Ratio

While P/E alone fails to identify a true value stock, PEG helps find the intrinsic value of a stock.

Zacks.com featured highlights include: DaVita, Hibbett, First Horizon, Universal Forest and Popular

Zacks.com featured highlights include: DaVita, Hibbett, First Horizon, Universal Forest and Popular

Anindya Barman headshot

5 Stocks With Amazingly Low EV/EBITDA Ratios to Own Now

We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.

The Zacks Analyst Blog Highlights: Exantas, Chemed, Viad, Arbor Realty and DaVita

The Zacks Analyst Blog Highlights: Exantas, Chemed, Viad, Arbor Realty and DaVita

Nalak Das headshot

Strong ISM Services Index Eases Recession Fears: 5 Top Picks

The ISM Services index clearly reflects that the U.S. economy has sustained its momentum despite heightened trade conflict and global economic slowdown.

Kinjel Shah headshot

5 Price-to-Book Value Picks for September

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

Why Is DaVita HealthCare (DVA) Down 5% Since Last Earnings Report?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA vs. CHE: Which Stock Is the Better Value Option?

John Blank headshot

When to Buy Global Markets?

It is NOT crazy to study global markets now.

John Blank headshot

Draghi Says Goodbye. Should You Care?

The answer is yes. A monetary policy regime change matters.

5 Stocks From the Best Performing Sectors in Q2

We have shortlisted solid stocks from the top-performing sectors in Q2 that should make a great addition to your portfolio.